LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)
This study has been completed.
Sponsor:
PETHEMA Foundation
Information provided by:
PETHEMA Foundation
ClinicalTrials.gov Identifier:
NCT00466258
First received: April 25, 2007
Last updated: November 23, 2009
Last verified: November 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | November 2009 |
| Primary Completion Date: | May 2009 (Final data collection date for primary outcome measure) |